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Multiple Sclerosis (MS) is being diagnosed in increasing numbers in metropolitan cities of India for which the availability
of specialist neurologists and magnetic resonance imaging (MRI) facilities are primarily responsible. Epidemiological data are
unavailable. Existing data have been obtained from small often retrospective studies from diﬀerent parts of the country. These
earlier studies suggested that optic nerve and spinal cord involvement are considerablyhigh, and that perhaps optic spinal MS was
the most prevalent form in India. On this basis it was also speculated that neuromyelitis optica (NMO) may be overrepresented
in Indians. However in recent times, prospective studies backed by MRI data have shown no distinct diﬀerences between MS
seen in the west and India. Sero positivity for NMO IgG is low though NMO phenotype disorders constitute nearly 20% of
demyelinating disorders in India. Genetic susceptibility for MS among Indians may be similar to that for white populations. In
the major histocompatibility complex (MHC), HLA DR1∗1501 has been strongly associated with MS in Indians. A recent study
that evaluated the established non-MHC multiple sclerosis loci in a small data set of Indian patients suggested a strong similarity
with white populations.This review highlights someof the background informationavailable on MS from India and so also some
recent studies that unveiled the disease characteristics in Indian patients.
1.Introduction
In the mid seventies in Kurtzke’s MS world map [1]I n d i a
was included in the list of countries belonging to the low
prevalence zone (<5/100,000). Even at that time, it was
believed that in developing countries there was underesti-
mation of disease prevalence for MS. Poser [2] mentioned
paucity of neurologists, paucity of postmortem examina-
tions, and unavailability of conﬁrmatory test procedures
such as neuroimaging, evoked potential studies, and reliable
cerebrospinal ﬂuid examination as some of the several prob-
lems in analyzing data from tropical countries. Record
keepingandlong-termfollowupofpatientshaveseen serious
limitations in all but the teaching hospitals and continue to
hinder data collection and analysis of diseases in India. A
decade later, there has been indirect evidence from hospital
statistics in India suggesting that the number of cases
diagnosed per year may have nearly doubled [3, 4]. This
may be partly due to early detectionespecially since in recent
times, MRI has become mandatory in all teaching hospitals
in the country. Additionally there has been an increase in
neurologists and also greater awareness which has resulted
in white matter diseases including MS being increasingly
diagnosed. In India public/teaching hospitals generally see
patients from a lower socioeconomic background who visit
hospitals with severe disease, males being given priority
over females for seeking medical attention. These factors
invariably hamper quality of data acquired from such
settings.
2.Prevalence ofMS inIndia
Neuroepidemiological studies have been done in the south-
ern parts of the country and have failed to capture MS cases
in the community [5]. A crude prevalence of approximately
1.33/100,000 was reported by Singhal [6] in the mid eighties
from the west coast of India. Hospital-based studies in India
have shown that over the last decade, the total proportion
of MS-related neurology department admissions increased
from 1.58% to 2.54% [4]. This data is supported by the2 Autoimmune Diseases
Multiple Sclerosis International Federation World MS Atlas,
which projects a prevalence of 3/100,000, which is nearly
triple the estimate of previous reports. Geographically north
west India (above 15◦ N latitude) saw 4.15 new cases of MS
per year as compared to 3.2 cases per year from south India
(below 15◦ N latitude) [7]. The one exception is the Parsi
population of India in whom Wadia and Bhatia [8]o b s e r v e d
a prevalence of 26/100,000. The Parsis (Zorastrians) origi-
nated from the Pars province ofIran. Recentepidemiological
studieshaveshown ahigh prevalenceofMSin Iran especially
in Ishfahan province [9]t h a ta d j o i n sP a r s .
3.MultipleSclerosisinIndia; Phenotypic
DifferencesfromWesternPopulation
Early literatureon MSfrom diﬀerentparts ofIndia suggested
that there was high prevalence of optic and spinal cord
involvement. In 1985 Jain and Maheshwari [7] published
data on 354 cases of MS from 9 diﬀerent centers in India.
Optic neuritis (OPN) as the initial presentation was seen in
22.2–58 % of cases seen at 5 of these centers. Recent studies
have shown a frequency of 23.6% from the north west [10],
44% from the south of the country [11], and 53.3% [12]
from the east of the country which is signiﬁcantly high as
compared to western data. In patients of North American
and Europeanorigin opticneuritiswas noted tobe the initial
presentation in only 17.2 % of patients [13]. Acute onset of
motor weakness was the next common initial presentation
seen in 27–31% of Indian patients [10, 12]. A comparison in
symptom at onset in patients admitted to a national hospital
in south India before and after the mid eighties showed a
dramatic reduction in spinal cord dysfunction by as much as
50% [11]. The authors attribute it to better awareness, early
investigations including MRI and earlier diagnosis when
patients present with milder symptoms.
4.Neuromyelitis Optica (NMO) among Indian
Demyelinating Disorders
In earlier literature on MS in India [6, 7]t h ed i a g n o s i s
of NMO was based on the descriptions by Shibasaki et al.
[14]. It was limited to patients who showed “acute bilateral
visual impairment and transverse spinal cord lesions, either
concomitantly or within a short interval with or without
subsequent improvement.” The last decade has seen a major
change in perception of NMO with a number of revisions
in the diagnostic criteria [15–17]. Seen predominantly
i nm i d d l ea g e dw o m e n ,t h i sd i s o r d e ri sc h a r a c t e r i z e db y
recurrent and severe involvement of optic nerve and spinal
cord, with longitudinal spinal cord lesions and atypical brain
lesions. Therein lies the dilemma in understanding how
common it is among Indian CNS demyelinating disorders,
wherein optic spinal presentations are common. Winger
chuck et al. [17] have compiled available literature on NMO
in India which included 59 cases reported between 1950 and
2006. They constituted roughly 9–24% of all demyelinating
disorders seen in each series. There is not enough data
availablenor long-term followup onthese patientsto suggest
there was severe visual loss or disproportionate spinal cord
dysfunction in the subset with optic spinal presentation. In
studies backed by MRI data [17, 18], MRI morphological
data including length of spinal cord segments involved is not
available.Thehighfrequencyofopticandspinalinvolvement
cannot be therefore loosely translated into a possible high
prevalenceof NMO.Jain and Maheshwari [7] compilation of
354 cases of MS has been widely quoted in western literature
as evidence for high prevalence of NMO in India. In their
series 22–58% of patients reported had attacks conﬁned to
the spinal cord and optic nerve. The authors have noted
that 33/354 cases (10%) had neuromyelitis optica as deﬁned
by Shibasaki et al. [14]. It is arguable that this deﬁnition
was restrictive and there could have been higher numbers
of NMO if considered in the light of current diagnostic
criteria. This is not likely the case as shown by contemporary
studies involving Indian patients, which correlated clinical
presentation in MS alongside detailed MRI data. Mani et
al. [19] compared 81 Indian with American MS patients
matched for age, gender and duration of MS. There were
no signiﬁcant clinical or radiological diﬀerences between the
two groups. NMO constituted 6% of Indian cases though
44% of patients in their Indian series had optic spinal
presentation. In a prospective and longitudinal study of CNS
demyelinating disorders which included 51 patients, Pandit
et al. [20] found 47% of their MS cases have clinical attacks
conﬁned to the optic nerve and spinal cord. Yet NMO was
diagnosed (Winger chuck et al. criteria [16] 1999) in only
5%.
Neuromyelitis optica Immunoglobulin G (NMO IgG)
seropostivity in Indian patients has been reported [21].
Pandit et al. analyzed NMO-IgG status in 78 consecutive
cases obtained from their demyelination registry. In this
study 62/78 (80%) patients belonged to the NMO spectrum.
Longitudinally extensive transverse myelitis was seen in
39/78 (50%) and included all cases of NMO, ATM, and
recurrent ATM. Neuromyelitis optica-IgG was positive in
3/78 patients (3.8%), one each of NMO, optic spinal MS
and recurrent acute transverse myelitis. Seropositive patients
were all women and had late onset disease. Two of the three
patients had optic neuritis and severe visual impairment
and became wheel chair bound within 5 years of disease
onset. Seronegative patients with long cord involvement
were 36/78 (46%). They had a male/female ratio of 2:1.
Assistance for mobility was required by 12/36 (33%). The
remaining 24/78 (66.7%) patients who were seronegative
and had long spinal cord lesions recovered well between
attacks and remained ambulant 4–7 years after disease onset
[22]. Asimilar benign outcomehas been described forNMO
phenotype disorders in one other Indian study. Pradhan
and Mishra [23] described 6 patients (3 male and 3 female)
with recurrent optic neuritis and myelitis with documented
long cord lesions on MRI of the spinal cord and normal
MRI brain. These patients followed up for 2–10 years
had good recovery in visual functions following OPN with
only one patient requiring assistance to walk. Current data
therefore appears to indicate that although optic and spinal
cord presentations of CNS demyelinating diseases may beAutoimmune Diseases 3
common in India, NMO meeting current diagnostic criteria
may be no more common in India than in the west.
5.EnvironmentalFactorsImplicated in
MS in India
Studies have shown that migration from low MS areas to
high MS areas before the age of 15 increased the risk of
MS in nonwhite populations, including Indians [24, 25]. It
is now clear that the rate of multiple sclerosis in second
generation (UK born) Asians and ﬁrst generation Asians
coming to the UK as children, is signiﬁcantly higher than in
ﬁrst generation (migrant) adult individuals. Ethnicity may
confer some degree of protection against the increased risk.
Thus in North America and the UK, MS increases among
immigrants from India, while it remains low in immigrants
from East Asia [26]. Geographical data indicates that MS
is more common as distance from equator increases. This
geographic variation may at least in part be attributable to
environmental factors and be considered a reason for lower
prevalence among Indians.
According to the “hygiene hypothesis” proposed in the
1960’s [27] children in areas where MS is rare are more
likely to show evidence of childhood viral infections. Higher
prevalenceofMSisseenwheresanitationandsocioeconomic
status are good. In this context, Singhal and Wadia [28]i n
their study of 30 patients from the Mumbai region observed
that MS patients were mostly from higher socioeconomic
status. Parsis of India in whom MS is highly prevalent
are also an aﬄuent community. A strong argument against
the hygiene concept is that the aﬄuent would have better
opportunities to seek specialist care and have a diagnosis for
their disease.
There are no large-scale studies which addressed speciﬁc
environmental factors related to MS. Khadilkar et al. [29]
have compared 63 patients with clinically deﬁnite MS with
age, and sex-matched controls and evaluated the role of
childhood viral infections, diet, evidence of concomitant
autoimmune disorders, and smoking.Their study showed a
signiﬁcant association in history of childhood mumps (P<
.01, odds ratio (OR) = 3, conﬁdence interval (CI) = 1.3–
7.2), and positive history of autoimmune diseases (P<. 05,
OR = 2.8, CI = 1.2–6.8) among Indians with MS. There was
a trend for association of MS among smokers in that 7 out of
10 smokers in Khadilakar’s data set had MS.
6.GeneticSusceptibilityforMS inIndians
The association between susceptibility to multiple sclerosis
and the human leukocyte antigen (HLA) genes has been
extensively studied in European and migrant European
populations but the role of these genes in Asian (especially
fromtheIndian subcontinent)multiplesclerosishasreceived
almost no attention. The HLA allele frequencies found in
this population, and the patterns of correlation (linkage dis-
equilibrium) between these alleles is substantially diﬀerent
from that seen in other more extensively studied ethnic
groups emphasising the potentially informative nature of
a study of these genes in Asians. A few small serological
studies considering the class I genes were performed in the
1980’s and found association with HLA-B12 [30, 31]r a t h e r
than B7. Subsequently analysis of the class II HLA genes,
DRB1, DQA1, and DQB1 was attempted in a limited
number of patients and revealed the expected association
with the European susceptibility haplotype DRB1∗1501—
DQB1∗0602 [32, 33]. In considering the merits of this pop-
ulation in connection with the genetic analysis of multiple
sclerosis it is relevant to note that although DR2 is actually
mor ecommoninAsiansthaninE ur opeans,theDRB1 ∗1501
allele (the main subtype of DR2 in Europeans) is notably
less common (allele frequency 8% in Asians as compared
to 15% in Europeans) (http://www.allelefrequencies.net/).
In Asians the other subtypes of DR2 (the DRB1∗1502
and DRB1∗16 alleles) are more common and the extent
of linkage disequilibrium (LD) between DRB1∗1501 and
DQB1∗0602 is signiﬁcantly less intense [34]. As described
above populations where the established risk allele (hap-
lotype) is uncommon have been especially informative
regarding theeﬀectsattributabletootherallelesandloci[35].
StudyingpopulationswithalternatepatternsofLDhavebeen
helpful in disentangling the eﬀects of linked loci [36]. These
factors suggest that a genetic analysis of the MHC region
in Asian patients is likely to be highly informative. Recently
eﬀortshavebeenfocusedonevaluatingtheroleofestablished
nonMHC disease susceptibility loci in Indian population
[37]. Fifteen MS loci outside of the major histocompatibility
(MHC) region that were previously identiﬁed and validated
with MS susceptibility through genomewide association and
replication studies in white populations were studied in 197
patients and unrelated controls. Despite the low power of
the study, nominal associations were seen especially with
interleukin-7 receptor alpha (IL7RA) and C type lectin
domain family 16-(CLEC16 A-) associated single nucleotide
polymorphisms (SNP’s) and the risk allele frequencies in
Indian Asian and white MS patients were comparable for
most SNP’s types. These preliminary observations suggest a
commonality in disease susceptibility genes for both Indian
and white populations.
7.Conclusions
Despite a modest estimated prevalence of MS in India
of 3/100,000, in this a nation of 1.2billion people, there
are probably more than 30,000 people with MS. With the
currently available data, it appears that MS in India and
in the west have similar presentations and risk factors.
Although the role of selected environmental factors that
confer susceptibility await evaluation, evidence suggests
that genetic susceptibility factors may be similar in Indian
and western populations, although this requires validation
through larger studies. Collaborative eﬀortsamong specialist
neurologists could help establish MS disease registries in
various parts of the country to determine the longitudinal
and natural history of this disease in India. Larger numbers
would also increase the power of studies of genetic and
environmental inﬂuences on MS in India.4 Autoimmune Diseases
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